• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扎那米韦载固体脂质纳米粒的工艺参数优化及其在 Caco-2 细胞模型中的细胞转运预测。

Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.

机构信息

College of Pharmaceutical Sciences, Soochow University, 199 Ren-Ai Road, Suzhou Industrial Park, Suzhou, Jiangsu 215123, PR China.

College of Pharmaceutical Sciences, Soochow University, 199 Ren-Ai Road, Suzhou Industrial Park, Suzhou, Jiangsu 215123, PR China.

出版信息

Int J Pharm. 2015 Jan 15;478(1):60-69. doi: 10.1016/j.ijpharm.2014.11.017. Epub 2014 Nov 12.

DOI:10.1016/j.ijpharm.2014.11.017
PMID:25448568
Abstract

The aim of this study was to optimize the process variables of zanamivir-loaded solid lipid nanoparticles (SLNs) and to predict their cellular transport across Caco-2 cell monolayers. Zanamivir-loaded SLNs were prepared by a double emulsion solvent evaporation method. The effects of process variables on the mean particle size and zeta potential of SLNs were investigated and the physicochemical properties of SLNs were characterized. In addition, the cytotoxicity and transport ability of SLNs were also studied in Caco-2 cell model. The mean particle size of drug-loaded SLNs was significantly affected by the process variables. The SLNs were prepared using glyceryl monosterate (1% polyvinyl alcohol (PVA) or 1.5% poloxamer 188 as surfactant) had a regular shape with a relatively lower mean particle size (324.2 and 224.9 nm, respectively), higher encapsulation efficacy (55.7 and 42.4%, respectively) and sustained drug release over 12h. The crystalline form of drug had been partly changed and no physicochemical interaction had occurred between drug and carriers in SLNs. The cell viability was approximately 100% even at a high concentration of blank SLNs. There was no remarkable difference in drug permeation between drug-loaded SLNs and drug solution at 2h, while drug-loaded SLNs showed a significant decrease in drug permeation compared with the drug solution at 4h. The process variables of zanamivir-loaded SLNs were successfully optimized in this study. However, these SLNs significantly reduced the transport ability of zanamivir across Caco-2 cell monolayers. Further studies are needed to fully understand the real absorption mechanism of developed SLNs.

摘要

本研究旨在优化扎那米韦负载固体脂质纳米粒(SLN)的工艺变量,并预测其穿过 Caco-2 细胞单层的细胞转运。扎那米韦负载的 SLN 通过双乳液溶剂蒸发法制备。考察了工艺变量对 SLN 平均粒径和 Zeta 电位的影响,并对 SLN 的理化性质进行了表征。此外,还在 Caco-2 细胞模型中研究了 SLN 的细胞毒性和转运能力。载药 SLN 的平均粒径受工艺变量的显著影响。使用甘油单硬脂酸酯(1%聚乙烯醇(PVA)或 1.5%泊洛沙姆 188 作为表面活性剂)制备的 SLN 呈规则形状,平均粒径较小(分别为 324.2nm 和 224.9nm),包封效率较高(分别为 55.7%和 42.4%),药物释放可持续 12 小时以上。药物的晶型已部分改变,药物与载体在 SLN 中未发生物理化学相互作用。即使在高浓度空白 SLN 的情况下,细胞活力也接近 100%。在 2 小时时,载药 SLN 与药物溶液之间的药物渗透没有明显差异,而在 4 小时时,载药 SLN 与药物溶液相比,药物渗透显著减少。本研究成功优化了扎那米韦负载 SLN 的工艺变量。然而,这些 SLN 显著降低了扎那米韦穿过 Caco-2 细胞单层的转运能力。需要进一步研究以充分了解开发的 SLN 的真实吸收机制。

相似文献

1
Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.扎那米韦载固体脂质纳米粒的工艺参数优化及其在 Caco-2 细胞模型中的细胞转运预测。
Int J Pharm. 2015 Jan 15;478(1):60-69. doi: 10.1016/j.ijpharm.2014.11.017. Epub 2014 Nov 12.
2
Topical Amphotericin B solid lipid nanoparticles: Design and development.局部用两性霉素B固体脂质纳米粒:设计与开发
Colloids Surf B Biointerfaces. 2016 Mar 1;139:17-24. doi: 10.1016/j.colsurfb.2015.07.032. Epub 2015 Dec 3.
3
Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.载卡维地洛固体脂质纳米粒的制备、体外评价及经口淋巴递药的统计学优化。
Pharm Dev Technol. 2014 Jun;19(4):475-85. doi: 10.3109/10837450.2013.795169. Epub 2013 May 23.
4
Development of Houttuynia cordata Extract-Loaded Solid Lipid Nanoparticles for Oral Delivery: High Drug Loading Efficiency and Controlled Release.鱼腥草提取物负载固体脂质纳米粒的研制及其口服给药:高载药量和控制释放。
Molecules. 2017 Dec 13;22(12):2215. doi: 10.3390/molecules22122215.
5
Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.使用响应面法制备和优化阿托伐他汀负载固体脂质纳米粒的系统方法。
Biomed Microdevices. 2018 Jun 26;20(3):53. doi: 10.1007/s10544-018-0285-5.
6
Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.采用质量源于设计方法,以单硬脂酸甘油酯为单一脂质制备姜黄素固体脂质纳米粒:对人乳腺癌细胞系的抗癌活性表征与评价
Curr Drug Deliv. 2018;15(9):1271-1283. doi: 10.2174/1567201815666180503120113.
7
Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.脂质基质对用于口服给药的瑞格列奈载药固体脂质纳米粒的影响。
Ther Deliv. 2010 Jul;1(1):63-73. doi: 10.4155/tde.10.7.
8
Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique.通过温度调制固化技术制备的载5-氟尿嘧啶固体脂质纳米粒的表征与评价
AAPS PharmSciTech. 2014 Dec;15(6):1498-508. doi: 10.1208/s12249-014-0168-x. Epub 2014 Jul 18.
9
Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.环孢素A负载型固体脂质纳米粒:制剂、工艺变量的优化及表征
Curr Drug Deliv. 2008 Jan;5(1):64-9. doi: 10.2174/156720108783331069.
10
Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, characterization, cell line studies and efficacy in schizophrenia.盐酸鲁拉西酮固体脂质纳米粒的口服给药制备:优化、表征、细胞系研究及在精神分裂症中的疗效。
Drug Dev Ind Pharm. 2019 Aug;45(8):1242-1257. doi: 10.1080/03639045.2019.1593434. Epub 2019 Jun 6.

引用本文的文献

1
Quality by design (QbD) based development and validation of RP-HPLC method for buserelin acetate in polymeric nanoparticles: Release study.基于质量源于设计(QbD)的聚乳酸纳米粒中醋酸布舍瑞林的反相高效液相色谱法的开发与验证:释放研究
Heliyon. 2024 Oct 10;10(20):e39172. doi: 10.1016/j.heliyon.2024.e39172. eCollection 2024 Oct 30.
2
Towards Effective Antiviral Oral Therapy: Development of a Novel Self-Double Emulsifying Drug Delivery System for Improved Zanamivir Intestinal Permeability.迈向有效的抗病毒口服疗法:开发一种新型自双乳化药物递送系统以提高扎那米韦的肠道通透性。
Pharmaceutics. 2023 Oct 23;15(10):2518. doi: 10.3390/pharmaceutics15102518.
3
Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment.
人类呼吸道病毒感染:基于纳米技术的预防和治疗方法的现状与未来前景
Life Sci. 2021 Aug 1;278:119561. doi: 10.1016/j.lfs.2021.119561. Epub 2021 Apr 26.
4
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects.用于药物递送的固体脂质纳米粒:药理学和生物药剂学方面
Front Mol Biosci. 2020 Oct 30;7:587997. doi: 10.3389/fmolb.2020.587997. eCollection 2020.
5
Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations.用于增强细胞摄取和生物利用度的冻干洛匹那韦纳米结构脂质载体:统计优化、体外和体内评价
Pharmaceutics. 2019 Feb 25;11(2):97. doi: 10.3390/pharmaceutics11020097.
6
Combination of Roll Grinding and High-Pressure Homogenization Can Prepare Stable Bicelles for Drug Delivery.滚磨与高压均质化相结合可制备用于药物递送的稳定双分子层囊泡。
Nanomaterials (Basel). 2018 Dec 3;8(12):998. doi: 10.3390/nano8120998.
7
Lyophilized Hybrid Nanostructured Lipid Carriers to Enhance the Cellular Uptake of Verapamil: Statistical Optimization and In Vitro Evaluation.冻干混合纳米结构脂质载体增强维拉帕米的细胞摄取:统计优化与体外评价
Nanoscale Res Lett. 2018 Oct 15;13(1):323. doi: 10.1186/s11671-018-2744-6.
8
Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs.测量纳米颗粒结合药物肠道吸收方法的进展
Int J Mol Sci. 2016 Jul 21;17(7):1171. doi: 10.3390/ijms17071171.